MODALTIN Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for MODALTIN with the United States Patent and Trademark Office. The USPTO has given the MODALTIN trademark a serial number of 88196892. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Tonix Pharmaceuticals, Inc.. The MODALTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
modaltin

General Information

Serial Number88196892
Word MarkMODALTIN
Filing DateFriday, November 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTonix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameTonix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2022SOU EXTENSION 5 GRANTED
Sunday, November 28, 2021SOU EXTENSION 5 FILED
Tuesday, February 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 5, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, January 5, 2022EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 5, 2022PETITION TO REVIVE-GRANTED
Wednesday, January 5, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, January 3, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 3, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 4 GRANTED
Thursday, May 13, 2021SOU EXTENSION 4 FILED
Thursday, May 13, 2021TEAS EXTENSION RECEIVED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2020SOU EXTENSION 3 GRANTED
Thursday, October 29, 2020SOU EXTENSION 3 FILED
Thursday, October 29, 2020TEAS EXTENSION RECEIVED
Saturday, May 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2020SOU EXTENSION 2 GRANTED
Thursday, April 30, 2020SOU EXTENSION 2 FILED
Thursday, April 30, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU EXTENSION 1 GRANTED
Monday, November 25, 2019SOU EXTENSION 1 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 21, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

modaltin disorders system disorder endocrine skeletal musculo musculoskeletal neurological diseases related